Structural insights into human GPCR protein OA1: a computational perspective

Human ocular albinism type 1 protein (OA1)—a member of the G-protein coupled receptor (GPCR) superfamily—is an integral membrane glycoprotein expressed exclusively by intracellular organelles known as melanocytes, and is responsible for the proper biogenesis of melanosomes. Mutations in the Oa1 gene are responsible for the disease ocular albinism. Despite its clinical importance, there is a lack of in-depth understanding of its structure and mechanism of activation due to the absence of a crystal structure. In the present study, homology modeling was applied to predicting OA1 structure following thorough sequence analysis and secondary structure predictions. The predicted model had the signature residues and motifs expected of GPCRs, and was used for carrying out molecular docking studies with an endogenous ligand, l-DOPA and an antagonist, dopamine; the results agreed quite well with the available experimental data. Finally, three sets of explicit molecular dynamics simulations were carried out in lipid bilayer, the results of which not only confirmed the stability of the predicted model, but also helped witness some differences in structural features such as rotamer toggle switch, helical tilts and hydrogen bonding pattern that helped distinguish between the agonist- and antagonist-bound receptor forms. In place of the typical “D/ERY”-motif-mediated “ionic lock”, a hydrogen bond mediated by the “DAY” motif was observed that could be used to distinguish the agonist and antagonist bound forms of OA1. In the absence of a crystal structure, this study helped to shed some light on the structural features of OA1, and its behavior in the presence of an agonist and an antagonist, which might be helpful in the future drug discovery process for ocular albinism.

[1]  J. Ballesteros,et al.  Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.

[2]  K. Hideg,et al.  Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. , 1993, Science.

[3]  A. Ballabio,et al.  Ocular albinism: evidence for a defect in an intracellular signal transduction system , 1999, Nature Genetics.

[4]  Rolf Apweiler,et al.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998 , 1998, Nucleic Acids Res..

[5]  Jae Yoon Chung,et al.  Correlation between Performance of QM/MM Docking and Simple Classification of Binding Sites , 2009, J. Chem. Inf. Model..

[6]  C. Tacchetti,et al.  The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. , 2005, Pigment cell research.

[7]  Siavoush Dastmalchi,et al.  Modelling the structures of G protein-coupled receptors aided by three-dimensional validation , 2007, BMC Bioinformatics.

[8]  E. Novellino,et al.  Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists. , 2005, Journal of medicinal chemistry.

[9]  Berk Hess,et al.  P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.

[10]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[11]  Judith Klein-Seetharaman,et al.  Dynamics in Rhodopsin , 2002, Chembiochem : a European journal of chemical biology.

[12]  M. Parrinello,et al.  Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.

[13]  D. Eisenberg,et al.  VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.

[14]  Ron O Dror,et al.  Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.

[15]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[16]  J. Ballesteros,et al.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.

[17]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[18]  David S. Cafiso,et al.  Identifying conformational changes with site-directed spin labeling , 2000, Nature Structural Biology.

[19]  M. Lohse,et al.  Measurement of the millisecond activation switch of G protein–coupled receptors in living cells , 2003, Nature Biotechnology.

[20]  Thomas Huber,et al.  Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. , 2008, Journal of molecular biology.

[21]  Marta Filizola,et al.  Modeling activated states of GPCRs: the rhodopsin template , 2006, J. Comput. Aided Mol. Des..

[22]  A. Ballabio,et al.  Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome , 1995, Nature Genetics.

[23]  Hao Fan,et al.  Refinement of homology‐based protein structures by molecular dynamics simulation techniques , 2004, Protein science : a publication of the Protein Society.

[24]  S. Karnik,et al.  Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor* , 2010, The Journal of Biological Chemistry.

[25]  H. Khorana,et al.  Structural features of the C-terminal domain of bovine rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[26]  Nagarajan Vaidehi,et al.  Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.

[27]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[28]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[29]  Tod D Romo,et al.  Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics. , 2010, Biophysical journal.

[30]  Rolf Apweiler,et al.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL , 1997, Nucleic Acids Res..

[31]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[32]  Tsutomu Kouyama,et al.  Crystal structure of squid rhodopsin , 2008, Nature.

[33]  R. Sowdhamini,et al.  Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. , 2009, Molecular bioSystems.

[34]  A. Ballabio,et al.  The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells , 2008, Human molecular genetics.

[35]  Francesca Fanelli,et al.  Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling , 2006, J. Comput. Aided Mol. Des..

[36]  Thomas B Woolf,et al.  Molecular dynamics simulation of dark-adapted rhodopsin in an explicit membrane bilayer: coupling between local retinal and larger scale conformational change. , 2003, Journal of molecular biology.

[37]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[38]  Stefano Costanzi,et al.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. , 2008, Journal of medicinal chemistry.

[39]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[40]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[41]  Robert D. Finn,et al.  The Pfam protein families database , 2004, Nucleic Acids Res..

[42]  S. A. Hassan,et al.  Key issues in the computational simulation of GPCR function: representation of loop domains , 2002, J. Comput. Aided Mol. Des..

[43]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..

[44]  D. Farrens,et al.  Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.

[45]  Manfred Burghammer,et al.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.

[46]  C. Decatur,et al.  L-DOPA Is an Endogenous Ligand for OA1 , 2008, PLoS biology.

[47]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[48]  Burkhard Rost,et al.  The PredictProtein server , 2003, Nucleic Acids Res..

[49]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.

[50]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[51]  Mark S. P. Sansom,et al.  Molecular dynamics simulations and membrane protein structure quality , 2008, European Biophysics Journal.

[52]  Christian Kandt,et al.  Setting up and running molecular dynamics simulations of membrane proteins. , 2007, Methods.

[53]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[54]  R. Wolf,et al.  Homology Modeling of the Transmembrane Domain of the Human Calcium Sensing Receptor and Localization of an Allosteric Binding Site* , 2004, Journal of Biological Chemistry.

[55]  Oliver P. Ernst,et al.  Crystal structure of metarhodopsin II , 2011, Nature.

[56]  Kenneth Lundstrom,et al.  An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs , 2009, Methods in molecular biology.

[57]  B. Kobilka G protein coupled receptor structure and activation. , 2007, Biochimica et biophysica acta.

[58]  K. Kidd,et al.  OA1 mutations and deletions in X-linked ocular albinism. , 1998, American journal of human genetics.

[59]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[60]  F. de Nigris,et al.  Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. , 1995, Human molecular genetics.

[61]  W. Hubbell,et al.  Sequence of late molecular events in the activation of rhodopsin , 2007, Proceedings of the National Academy of Sciences.

[62]  Cheng Zhang,et al.  Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.

[63]  A. Garcia,et al.  The membrane complex between transducin and dark-state rhodopsin exhibits large-amplitude interface dynamics on the sub-microsecond timescale: insights from all-atom MD simulations. , 2010, Journal of molecular biology.

[64]  T. Gudermann,et al.  The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. , 2002, Reviews of physiology, biochemistry and pharmacology.

[65]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[66]  D Bergsma,et al.  Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. , 2000, Drug design and discovery.

[67]  Nagarajan Vaidehi,et al.  Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.

[68]  S. Orlow,et al.  Ocular albinism type 1: more than meets the eye. , 2001, Pigment cell research.

[69]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[70]  J. Simms,et al.  Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified. , 2007, The Journal of biological chemistry.

[71]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[72]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[73]  A. Ballabio,et al.  Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1. , 2000, Human molecular genetics.

[74]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[75]  Prashant V Desai,et al.  Homology modeling of G-protein-coupled receptors and implications in drug design. , 2006, Current medicinal chemistry.

[76]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[77]  B. Kobilka,et al.  New G-protein-coupled receptor crystal structures: insights and limitations. , 2008, Trends in pharmacological sciences.

[78]  A. Ballabio,et al.  Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. , 2000, Human molecular genetics.

[79]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[80]  R. Piccirillo,et al.  The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. , 2006, Pigment cell research.

[81]  B. Kobilka Agonist-induced conformational changes in the beta2 adrenergic receptor. , 2002, The journal of peptide research : official journal of the American Peptide Society.